Efficacy screening
DefiniGEN's Phenotypic Screening Service helps you move quickly and efficiently from screening library to promising candidates.
Combining our expertise at generating iPSC-derived hepatocyte cellular models of disease with our wide panel of bespoke bioassays. We work as partners with your team to design and implement in-house screening of small molecules, RNAi/oligonucleotide therapeutics, AAVs and virtually any modality so you can advance your program at speed.
